Zentek Invited to Present Albany Graphite Purification Results at the 26th International Nuclear Graphite Specialists Meeting

Zentek CEO Mohammed Jiwan is scheduled to present bench-scale results on acid-free purification of Albany graphite to 5N at INGSM-26 in Osaka on October 22, 2026. The presentation will seek specialist input on the material’s target specification; the article also cites an IAEA projection that global nuclear capacity could rise from 377 GW to 561–992 GW by 2050.

Analysis

The value signal is not the 5N bench-scale result itself, but whether it can translate into nuclear-grade material that meets application-specific requirements at viable scale and cost. Purity alone does not establish suitability: reactor graphite qualification also depends on properties such as impurity profile, strength, grain structure and irradiation behavior. A specialist presentation and request for feedback are useful technical steps, not evidence of customer qualification, an offtake agreement or commercial economics.

Near term, ZEN may see event-driven attention ahead of October 22, but the long-dated nuclear buildout narrative is unlikely to resolve the key company-specific uncertainties. Over 1–3 months, the meaningful catalysts are disclosed target specifications, reproducible scale-up data, independent validation and evidence of engagement with prospective users. Over 6–18 months, qualification timelines and capital requirements could matter more than headline purity. Qualified incumbent suppliers, including Toyo Tanso, may benefit from established customer and process relationships; a new entrant would need to displace that qualification advantage, not merely demonstrate a lab result.

Contrarian view: broad nuclear-capacity projections can encourage investors to capitalize distant demand too early. Graphite demand is not automatically addressable demand for Albany material, and reactor designs may require different specifications. Treat ZEN as a speculative development story rather than a near-term nuclear-demand proxy. The thesis weakens if follow-up work fails to demonstrate repeatable product quality, relevant application specifications or a credible route to commercial-scale economics.

Key Decisions for Investors

• No fundamental trade on the announcement alone. Avoid chasing any pre-event volume or price spike; the presentation is a technical-feedback catalyst, not a commercial milestone.
• Keep ZEN on a catalyst watch through the October 22 presentation. Upgrade the thesis only if the company provides independently verifiable, repeatable results tied to a defined nuclear application and a plausible scale-up path.
• For existing exposure, size against development-stage and liquidity risk. Reassess if the presentation offers no application-specific specification or if subsequent updates fail to show validation, customer qualification progress, or credible economics.
• Do not use nuclear-capacity forecasts as a proxy for ZEN revenue. Track evidence of user engagement and qualification milestones over the next 6–18 months; absent those, the demand narrative remains too remote to support a durable rerating.